Drug Interaction Report

Sertraline and Cangrelor: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Sertraline

No brand names on record
+

Cangrelor

Kengreal
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 532 documented Sertraline interactions, 477 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Combining sertraline with cangrelor can add to bleeding risk, so watch for any unusual bleeding and report it. Your care team can manage this with close monitoring, especially since cangrelor is only given short-term in a monitored setting.

These two medicines can add up to a higher chance of bleeding. Sertraline is an antidepressant that also affects tiny blood cells called platelets, which help you form clots. Cangrelor is a strong IV blood thinner given during heart procedures to keep platelets from clumping. When both are on board, your blood may be a little slower to clot.

You might notice easier bruising, nosebleeds, or bleeding that takes longer to stop. The good news: your care team knows about this and watches for it closely, especially in the hospital setting where cangrelor is used. Let them know about any unusual bleeding, and keep taking your medicines as prescribed unless your doctor says otherwise.

Effect: Additive risk of bleeding when sertraline (SSRI) is combined with cangrelor (IV P2Y12 platelet inhibitor).

  • Mechanism: Sertraline depletes platelet serotonin, impairing serotonin-mediated platelet aggregation; this adds to cangrelor's direct P2Y12 blockade (pharmacodynamic, additive on hemostasis). No prodrug or CYP-based component.
  • Direction/magnitude: Increased bleeding risk; magnitude not quantified for this pair.
  • Onset: Unspecified; cangrelor acts within minutes IV.
  • Evidence: Theoretical, extrapolated from SSRI/antiplatelet epidemiologic data.
  • Management: Monitor for bleeding (epistaxis, ecchymosis, hematoma, petechiae, major hemorrhage); counsel patient. Cangrelor is periprocedural, so this is a short, closely monitored exposure.
Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

An increased risk of bleeding

Interaction Deep Dive

Care should be taken when a SSRI is given together with an antiplatelet drug, since the combination can heighten the likelihood of bleeding events32. Using sertraline alongside an antiplatelet agent may increase the potential for bleeding, an effect possibly attributable to the influence of sertraline on serotonin release from platelets. Both case-control and cohort investigations have demonstrated that taking selective serotonin and norepinephrine reuptake inhibitors (for example, sertraline) in combination with antiplatelet agents is linked to a greater bleeding risk. The bleeding events that have been documented include epistaxis, ecchymosis, hematoma, petechiae, and hemorrhages that are life-threatening. If sertraline and an antiplatelet agent are administered at the same time, watch the patient for indications of increased bleeding and warn patients about the elevated bleeding risk 1.

Why it happens (mechanism)

Release of serotonin by platelets; additive effects on hemostasis

How to manage this interaction

This combination can be used when needed, but your care team will keep a closer eye on you for bleeding.

  • Keep taking both as prescribed unless your doctor tells you otherwise. Cangrelor is usually given only in the hospital for a short time.
  • Your team may monitor you more closely for signs of bleeding while both are in your system.
  • Watch for and report nosebleeds, easy bruising, unusual bleeding, blood in urine or stool, or bleeding that won't stop.
  • Tell your pharmacist and doctors about all your medicines, including over-the-counter pain relievers like aspirin or ibuprofen, which can add to bleeding risk.

Management is individual — confirm any change with your pharmacist or prescriber.

Literature reports

3 reports — tap to read

a) A retrospective study examined patients older than 50 years diagnosed with acute myocardial infarction (N=27,058). In this population, taking an SSRI together with any antiplatelet therapy raised the bleeding risk by 1.42-fold relative to aspirin alone, a significant increase. The combination of aspirin, clopidogrel, and an SSRI significantly elevated the risk by 2.35-fold compared with aspirin alone and by 1.57-fold compared with the combination of clopidogrel and aspirin 2.

b) A systematic review and meta-analysis covering 22 observational studies found that SSRI use carried a significant 1.55-fold higher risk of upper gastrointestinal bleeding (UGIB). Using SSRIs together with antiplatelet agents was linked to a 2.48-fold increase in the risk of UGIB (based on 3 studies) 3.

c) Case reports along with epidemiological investigations (case-control and cohort studies) have shown a link between the use of agents that impair serotonin reuptake and the occurrence of gastrointestinal bleeding. According to data from published observational studies, exposure to SSRIs, especially during the month prior to delivery, has been linked to a less than 2-fold increase in the risk of postpartum hemorrhage. Bleeding events associated with SSRIs and SNRIs have varied from ecchymosis, hematoma, epistaxis, and petechiae to hemorrhages that are life-threatening 1.

Common questions

Can I take Sertraline and Cangrelor together?

Combining sertraline with cangrelor can add to bleeding risk, so watch for any unusual bleeding and report it. Your care team can manage this with close monitoring, especially since cangrelor is only given short-term in a monitored setting. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Sertraline and Cangrelor interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Sertraline and Cangrelor interaction managed?

This combination can be used when needed, but your care team will keep a closer eye on you for bleeding. Keep taking both as prescribed unless your doctor tells you otherwise. Cangrelor is usually given only in the hospital for a short time. Your team may monitor you more closely for signs of bleeding while both are in your system. Watch for and report nosebleeds, easy bruising, unusual bleeding,… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Sertraline or Cangrelor need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (3)

  1. Product Information: ZOLOFT oral tablets, oral solution, sertraline hydrochloride oral tablets, oral solution. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. DailyMed
  2. Labos C, Dasgupta K, Nedjar H, et al: Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ 2011; 183(16):1835-1843. PubMed
  3. Jiang HY, Chen HZ, Hu XJ, et al: Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2015; 13(1):42-50. PubMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.